Navigation Links
Texas Cardiac Arrhythmia Institute at St. David's Medical Center Selected to Conduct Clinical Trial for Device to Treat Atrial Fibrillation
Date:10/7/2008

AUSTIN, Texas, Oct. 7 /PRNewswire/ -- The Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center has been selected as one of only a few sites in the nation to participate in an FDA-approved clinical trial for a new device to treat persistent atrial fibrillation. TCAI, an international treatment, training and research center specializing in heart rhythm disorders, is a partnership between St. David's Medical Center and Texas Cardiovascular Consultants.

"This is just another example of how TCAI is leading the nation in pioneering new treatments for atrial fibrillation," Dr. Rodney Horton, electrophysiologist, Texas Cardiac Arrhythmia, said. "We are proud to take part in this study that has the potential to greatly enhance the future treatment of A Fib."

Heart arrhythmias are very common, affecting more than two million people nationwide. Atrial fibrillation, or A Fib, is the most common heart arrhythmia. A Fib is a rhythm disorder that affects the electrical system, or "wiring," of the heart muscle. It is often treated with cardiac ablation -- a procedure that allows physicians to deliver energy directly to the heart muscle at precise points that trigger the arrhythmia, creating a lesion that blocks the pathway for the abnormal heart rhythm. The new study involves second generation software (Gen II) that uses a catheter believed to result in the formation of a more effective lesion.

"In the Gen II study, we are evaluating a revolutionary radiofrequency ablation catheter," Dr. Horton said. "This device is able to monitor the temperature at its tip, giving electrophysiologists the ability to better control the delivery of energy through the catheter and generate a more effective lesion." In traditional cardiac ablation, room temperature saline is injected through the catheter prior to the delivery of energy. Because standard catheters do not measure the temperature at the catheter's tip, overheating may occur, resulting in th
'/>"/>

SOURCE The Texas Cardiac Arrhythmia Institute at St. David?sMedical Center
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Vical Receives NIH Grant for an Immunotherapeutic Herpes DNA Vaccine; Herpes Experts at University of Washington and University of Texas to Conduct Preclinical Development
2. Texas Heart(R) Institute at St. Lukes Episcopal Hospital Initiates First Clinical Trial in the World to Treat a Heart Attack Patient with a Special Stem Cell Type
3. Caliper Life Sciences Optical Imaging Technology Selected to Aid Tuberculosis Research Efforts by the Texas A&M Health Science Center
4. Personalized Medicine - The Genomic Revolution in Cardiac Care
5. FAU Receives Patent for Invention Which Induces and Restores Cardiac Muscle Function
6. Signalife Completes Testing of Modules for Holter and Intra-Cardiac Monitor
7. Abbotts XIENCE(TM) V Everolimus Eluting Coronary Stent Shows Continued Superiority to TAXUS Stent in Reducing Major Adverse Cardiac Events in SPIRIT III Clinical Trial
8. Study Shows Vernakalant Hydrochloride is Effective in Conversion to Normal Heart Rhythm in Atrial Fibrillation Patients Following Cardiac Surgery
9. FDA Concludes There is No Increased Risk of Cardiac Events for Patients Treated with omeprazole and NEXIUM(R) (esomeprazole magnesium)
10. Do-It-Yourself Cardiac Bypass Surgery: All You Need is Walking Shoes
11. Innocoll Announces Dosing of First Patient in US Phase 3 Clinical Trial to Investigate CollaRx(R) GENTAMICIN SURGICAL IMPLANT for the Prevention of Surgical Site Infections in Cardiac Surgery Patients

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...,N.J.,Nov.25/PRNewswire/--RegadoBiosciences,apriva...icaptamerswithactivecontrolagents,announcedthatDav...iperJaffray21stAnnualHealthCareConferenceattheNewY...willbegivenat1:10pm(EST)onTuesday,December1andwill...sontheleaddevelopmentprogram,theanticoagulantsyste...
(Date:11/25/2009)...K,N.J.,Nov.25/PRNewswire/--SwissrayInternational,I... ddR )systems,announcedtodaythatitsoperationshaveb...wtowardsgrowingSwissray,smedicalimagingbrand.Theac...aswellascontractsandinventory.After25yearsofsucces...ftechnologicaladvancementswithstableandsteadygrowt...
(Date:11/25/2009)...25/PRNewswire/--Reportlinker.comannouncesthatanewm..., IntranasalDrugDelivery-USMarketTrends&Analy...al-Drug-Delivery---US-Market-Trends--Analysis.html...inganexpansionoftherapeuticapplicationsfromthedeli...ryofsystemictherapeuticdrugs.Thefutureofthetechnol...
Breaking Medicine Technology:Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2Swissray International Announces New Ownership 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 2Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 3Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 4Reportlinker Adds Intranasal Drug Delivery - US Market Trends & Analysis 5IntelliSoft Group and Amerinet Inc Form Partnership to Transform Healthcare Delivery of Quality Patient Safety and Care 61876 1IntelliSoft Group and Amerinet Inc Form Partnership to Transform Healthcare Delivery of Quality Patient Safety and Care 61876 2New Haven Dental Group Expands Their Vision 61872 1New Haven Dental Group Expands Their Vision 61872 2Actuaries to Senate 3A Strengthen Individual Mandate 61868 1Actuaries to Senate 3A Strengthen Individual Mandate 61868 2
...1 In a boost to,HIV prevention research, Merck & ...cense to the non-profit International Partnership ...oviral compound for use as a,potential vaginal mic...r of a class of antiretroviral,molecules known as ...n by,preventing the virus from fusing with the sur...
...of MA-17 trial data provides evidence for, poten...after finishing tamo... class with data demonstrating this potential ben..., - Half of all breast cancer recurrences occur ... diagnosis, - Separate analysis published in ...
Other Medicine Technology:Microbicide Developer Receives License for Novel HIV Microbicide Candidate From Merck & Co., Inc. 2Microbicide Developer Receives License for Novel HIV Microbicide Candidate From Merck & Co., Inc. 3VIDEO: Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy 2VIDEO: Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy 3VIDEO: Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy 4VIDEO: Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy 5VIDEO: Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy 6VIDEO: Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy 7
(Date:11/25/2009)...e/--Thanksgivingmealswillbedeliveredtoapproximatel...nkstoFaithInAction/VolunteerActionforAging,aprogra...HealthPlan.Formorethan17yearstheseorganizationshav...vingmealstoseniorsinneedinLongBeach,Lakewood,Signa.... ,, "Ourwarmholidaymealsaredeliveredtopeoplewh...
(Date:11/25/2009)...wswire/--TheBlackAIDSInstituterecentlyheldBoardofD...010. ,, ThenewBoardMembersareahighlydiversegrou...e,governmenthealthprograms,editorial,andbusinessen...rsonalbackgroundsincludingbothheterosexualandgayBl...esentingmultipleagegroups. ,, (Photo: http://ww...
(Date:11/25/2009)...ess,andPressJoinEfforttoEducate ,, MEMPHIS,Ten...ionalBipolarFoundationandtheMedicAlertFoundationre...ogram,whichisnowbeingwidelyacceptedasapreventivehe...lBipolarFoundationreceivedaproclamationofendorseme...fLouisianaMitchLandrieu.TheNationalBipolarFoundati...
(Date:11/25/2009)...atistically significant survival benefit from adju...tor (ER)-positive tumors had high levels of phosph...8-P), according to a brief communication published...l Cancer Institute . , Approximately 50% of brea...cal studies have shown that ER-alpha S118-P is req...
(Date:11/25/2009)...his simple question has been the focus of intense ...Modulates High Blood Pressure in Mice & Men, Does...tion has been the focus of intense research for ma... established a link between a novel gene, phosduci...ce as well as humans. The studies were directed by...
Breaking Medicine News(10 mins):Health News:SCAN Employees and Community Volunteers to Help Deliver One Thousand Thanksgiving Meals to Homebound Seniors 2Health News:Black AIDS Institute Announces 2010 Board Election Results 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3Health News:New stress-related gene modulates high blood pressure in mice and men 2
...ge-old conception that memory capacity is solely d... the brain, a recent research demonstrates that //...increase their capacity to remember what is really...y, does not depend on extra storage space in the b...
...nese city in northeastern China, has suspended dri...ation, fearing possibility of contamination by che..., northeastern China, Tuesday "made a U-turn by ad...ther reports said the city had suspended its publi...
...tals Group is planning expansion of its super-spec...elhi, and bigger units in Kolkata and Bangalore.//...ew hospital at Pitampura (in west Delhi) which wou...he existing 110-bed cardiac care hospital in Banga...
...ines were issued today by the National Institute f...ational Collaborating Centre for Mental Health,// ... obsessive-compulsive disorder (OCD) and body dysm... is characterized by the occurrence of obsessions ...
...ai International Forum on a Healthy City has raise...g specific groups such as young people, specially ...s.// Smoking, which still remains one of the lead...unicipal Center for Disease Prevention and Control...
...ate over the safety of artificial sweeteners got a... Control Council today stated that a rat study con... contradictory with the extensive scientific resea... of aspartame. The study, to be published in Envir...
Other Medicine News:Health News:Wockhardt Group Plans Hospital In Delhi By End-2007 2Health News:Aspartame, Artificial Sweetener, A Safe Bet! 2Health News:Aspartame, Artificial Sweetener, A Safe Bet! 3
Alkaline Phosphatase
Uric Acid (Uricase) (Single Reagent)
Uric acid FS TBHBA
Uric Acid
Medicine Products: